09.09.2014 Views

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

autism may exhibit dysfunction of the HPA system, but it is not clear whether<br />

altered neuroendrocrine regulation or altered responsiveness underlies the<br />

differences between children with <strong>and</strong> without autism. In order to provide<br />

preliminary data concerning HPA regulation <strong>and</strong> responsiveness, we compared<br />

circadian rhythms <strong>and</strong> response to a non-social, environmental stressor in<br />

children with <strong>and</strong> without autism. METHODS: Circadian rhythms of cortisol were<br />

estimated in children with (N=12) <strong>and</strong> without (N=10) autism via analysis of<br />

salivary samples collected in the morning, afternoon <strong>and</strong> evening on 2<br />

consecutive days. HPA responsiveness was assessed by examining the time<br />

course of changes in salivary cortisol in response to a mock MRI. RESULTS: Both<br />

groups showed expected circadian variation with higher cortisol concentration in<br />

morning than in the evening samples. The children with autism, but not typical<br />

children, showed a more variable circadian rhythm as well as statistically<br />

significant elevations in cortisol following exposure to a novel, nonsocial stimulus.<br />

CONCLUSIONS: The results suggest that children with autism process <strong>and</strong><br />

respond idiosyncratically to novel <strong>and</strong> threatening events resulting in an<br />

exaggerated cortisol response.<br />

Danfors, T., A. L. von Knorring, et al. (2005). "Tetrahydrobiopterin in the treatment of<br />

children with autistic disorder: a double-blind placebo-controlled crossover study." J Clin<br />

Psychopharmacol 25(5): 485-9.<br />

Twelve children, all boys, aged 4 to 7 years, with a diagnosis of autistic disorder<br />

<strong>and</strong> low concentrations of spinal 6R-l-erythro-5,6,7,8-tetrahydrobiopterin<br />

(tetrahydrobiopterin) were selected to participate in a double-blind, r<strong>and</strong>omized,<br />

placebo-controlled, crossover study. The children received a daily dose of 3 mg<br />

tetrahydrobiopterin per kilogram during 6 months alternating with placebo.<br />

Treatment-induced effects were assessed with the Childhood <strong>Autism</strong> Rating Scale<br />

every third month. The results showed small nonsignificant changes in the total<br />

scores of Childhood <strong>Autism</strong> Rating Scale after 3- <strong>and</strong> 6-month treatment. Post<br />

hoc analysis looking at the 3 core symptoms of autism, that is, social interaction,<br />

communication, <strong>and</strong> stereotyped behaviors, revealed a significant improvement<br />

of the social interaction score after 6 months of active treatment. In addition, a<br />

high positive correlation was found between response of the social interaction<br />

score <strong>and</strong> IQ. The results indicate a possible effect of tetrahydrobiopterin<br />

treatment.<br />

Deth, R., C. Muratore, et al. (2008). "How environmental <strong>and</strong> genetic factors combine<br />

to cause autism: A redox/methylation hypothesis." Neurotoxicology 29(1): 190-201.<br />

Recently higher rates of autism diagnosis suggest involvement of environmental<br />

factors in causing this developmental disorder, in concert with genetic risk<br />

factors. Autistic children exhibit evidence of oxidative stress <strong>and</strong> impaired<br />

methylation, which may reflect effects of toxic exposure on sulfur metabolism.<br />

We review the metabolic relationship between oxidative stress <strong>and</strong> methylation,<br />

with particular emphasis on adaptive responses that limit activity of cobalamin<br />

<strong>Autism</strong> <strong>Studies</strong> & <strong>Related</strong> <strong>Medical</strong> <strong>Conditions</strong> – <strong>TACA</strong> © Page 78

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!